Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER and MATTI ESKELINEN
In Vivo March 2022, 36 (2) 773-779; DOI: https://doi.org/10.21873/invivo.12764
MAARET ESKELINEN
1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: matti.eskelinen{at}kuh.fi
IINA SAIMANEN
1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RIIKA KOSKELA
2Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANU HOLOPAINEN
3Department of Clinical Chemistry, Eastern Finland Laboratory Center, Kuopio University Hospital, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TUOMAS SELANDER
4Science Service Center, Kuopio University Hospital, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTI ESKELINEN
1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 36 no. 2 773-779
DOI 
https://doi.org/10.21873/invivo.12764
PMID 
35241533

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received January 21, 2022
  • Revision received February 8, 2022
  • Accepted February 15, 2022
  • Published online March 2, 2022.

Copyright & License 
Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MAARET ESKELINEN1⇑*,
  2. IINA SAIMANEN1,*,
  3. RIIKA KOSKELA2,
  4. ANU HOLOPAINEN3,
  5. TUOMAS SELANDER4 and
  6. MATTI ESKELINEN1,*
  1. 1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;
  2. 2Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland;
  3. 3Department of Clinical Chemistry, Eastern Finland Laboratory Center, Kuopio University Hospital, Kuopio, Finland;
  4. 4Science Service Center, Kuopio University Hospital, Kuopio, Finland
  1. Correspondence to: Matti Eskelinen, MD, Ph.D., School of Medicine, University of Eastern Finland, P.O. Box 100, FI-70029 KYS, Finland. Tel: +358 17173311, Fax: +358 17172611, GSM: +358 400969444, e-mail: matti.eskelinen{at}kuh.fi
View Full Text

Statistics from Altmetric.com

Cited By...

  • 13 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 36, Issue 2
March-April 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients
MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER, MATTI ESKELINEN
In Vivo Mar 2022, 36 (2) 773-779; DOI: 10.21873/invivo.12764

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients
MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER, MATTI ESKELINEN
In Vivo Mar 2022, 36 (2) 773-779; DOI: 10.21873/invivo.12764
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Targeting AASS improves neurotoxicity and mitochondrial function in astrocyte models for pyridoxine dependent epilepsy
  • Free Interleukin 18 (IL-18F) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
  • Brief Pain Inventory (BPI) Pain Survey Versus Cysteine Protease Caspase-1 (Casp1) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
  • Google Scholar

More in this TOC Section

  • NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder
  • Stable “Salivary Viral Road Ratios” in Individuals Infected With Omicron Variants
  • HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer
Show more Clinical Studies

Keywords

  • Benign disease
  • cancer
  • lipid peroxidation
  • plasma 4-hydroxynonenal
  • pain score following surgery
In Vivo

© 2026 In Vivo

Powered by HighWire